Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BY.1.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BM.1.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BM.2.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CW.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.42NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAY.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.46NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.17.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.562NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.219NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
N.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XANSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AZ.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.114NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.39NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.199NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.112NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.123NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.143NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.48NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.46.6.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.360NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.49NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.347NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.195NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.321NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.379NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.78NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.231NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.49NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.67NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.190NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.120NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AM.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AA.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.249NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AA.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.505NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.406NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.115NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AA.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.133NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.466NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used